2262 Stock Overview
Engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 2262 from our risk checks.
Jiangsu Nhwa Pharmaceutical Co., LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.00 |
| 52 Week High | CN¥31.98 |
| 52 Week Low | CN¥20.64 |
| Beta | 0.033 |
| 1 Month Change | -3.64% |
| 3 Month Change | -4.21% |
| 1 Year Change | -24.47% |
| 3 Year Change | 47.44% |
| 5 Year Change | 111.01% |
| Change since IPO | 82.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2262 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.9% | -3.6% | -2.8% |
| 1Y | -24.5% | -14.4% | -11.7% |
Return vs Industry: 002262 underperformed the CN Pharmaceuticals industry which returned -14.4% over the past year.
Return vs Market: 002262 underperformed the CN Market which returned -11.7% over the past year.
Price Volatility
| 2262 volatility | |
|---|---|
| 2262 Average Weekly Movement | 4.7% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in CN Market | 10.5% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 002262 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002262's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 5,394 | Jiaquan Sun | www.nhwa-group.com |
Jiangsu Nhwa Pharmaceutical Co., LTD engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally. The company’s products are used for treatment of anesthesia, analgesia, mental and neurological diseases, narcotic, psychiatry, and neurological categories, as well as APIs. It sells its products through hospitals, private hospitals, online pharmacies, and chain pharmacies.
Jiangsu Nhwa Pharmaceutical Co., LTD Fundamentals Summary
| 2262 fundamental statistics | |
|---|---|
| Market cap | CN¥23.17b |
| Earnings (TTM) | CN¥1.07b |
| Revenue (TTM) | CN¥5.22b |
21.6x
P/E Ratio4.4x
P/S RatioIs 2262 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2262 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.22b |
| Cost of Revenue | CN¥1.49b |
| Gross Profit | CN¥3.73b |
| Other Expenses | CN¥2.66b |
| Earnings | CN¥1.07b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.07 |
| Gross Margin | 71.55% |
| Net Profit Margin | 20.59% |
| Debt/Equity Ratio | 1.0% |
How did 2262 perform over the long term?
See historical performance and comparison